ES527714A0 - Procedimiento para la obtencion de tetrapeptidos sustituidos - Google Patents

Procedimiento para la obtencion de tetrapeptidos sustituidos

Info

Publication number
ES527714A0
ES527714A0 ES527714A ES527714A ES527714A0 ES 527714 A0 ES527714 A0 ES 527714A0 ES 527714 A ES527714 A ES 527714A ES 527714 A ES527714 A ES 527714A ES 527714 A0 ES527714 A0 ES 527714A0
Authority
ES
Spain
Prior art keywords
tetrapeptides
procedure
obtaining substituted
substituted
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES527714A
Other languages
English (en)
Other versions
ES8606394A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES527714A0 publication Critical patent/ES527714A0/es
Publication of ES8606394A1 publication Critical patent/ES8606394A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES527714A 1982-12-03 1983-12-01 Procedimiento para la obtencion de tetrapeptidos sustituidos Expired ES8606394A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH704782 1982-12-03
CH363583 1983-07-01

Publications (2)

Publication Number Publication Date
ES527714A0 true ES527714A0 (es) 1986-04-01
ES8606394A1 ES8606394A1 (es) 1986-04-01

Family

ID=25693492

Family Applications (2)

Application Number Title Priority Date Filing Date
ES527714A Expired ES8606394A1 (es) 1982-12-03 1983-12-01 Procedimiento para la obtencion de tetrapeptidos sustituidos
ES543488A Expired ES8702437A1 (es) 1982-12-03 1985-05-24 Procedimiento para la obtencion de tetrapeptidos sustituidos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES543488A Expired ES8702437A1 (es) 1982-12-03 1985-05-24 Procedimiento para la obtencion de tetrapeptidos sustituidos

Country Status (11)

Country Link
US (1) US4595677A (es)
EP (1) EP0111266A3 (es)
AU (1) AU2193783A (es)
DD (1) DD217807A5 (es)
DK (1) DK555983A (es)
ES (2) ES8606394A1 (es)
FI (1) FI834345A7 (es)
GR (1) GR79104B (es)
IL (1) IL70365A0 (es)
NO (1) NO834441L (es)
PT (1) PT77761B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751299A (en) * 1983-11-18 1988-06-14 Takeda Chemical Industries, Ltd. Optically active β-lactams and method of their production
DK110285A (da) * 1984-03-12 1985-09-13 Pfizer Polypeptider og polypeptidderivater indeholdende statin eller derivater deraf og farmaceutiske praeparater
US4636491A (en) * 1984-03-27 1987-01-13 Merck & Co., Inc. Renin inhibitory peptides having improved solubility
EP0163237A3 (en) * 1984-05-29 1988-04-27 Merck & Co. Inc. Di- and tri-peptidal renin inhibitors
US4880781A (en) * 1984-08-06 1989-11-14 The Upjohn Company Renin inhibitory peptides containing an N-alkyl-histidine moiety
EP0181110A3 (en) * 1984-10-22 1988-05-11 Kissei Pharmaceutical Co. Ltd. Histidine derivatives as renin inhibitors
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives
EP0184855A3 (en) * 1984-12-14 1989-05-03 Abbott Laboratories Resin inhibiting compounds
FR2585708B1 (fr) * 1985-07-31 1989-07-07 Sanofi Sa Derives aminoalcools peptidiques inhibiteurs de la resine et des proteases acides, leur procede de preparation et leur application en therapeutique
PT82077B (fr) * 1985-02-26 1987-09-25 Sanofi Sa Procede pour l'obtention des derives aminoalcools peptidiques inhibiteurs de la renine et des proteases acides
DE3512128A1 (de) * 1985-04-03 1986-10-09 Merck Patent Gmbh, 6100 Darmstadt Peptide
WO1986006379A1 (en) 1985-04-19 1986-11-06 The Upjohn Company Dihalo-statine substituted renin inhibitors
US4882420A (en) * 1985-04-19 1989-11-21 The Upjohn Company Dihalo-statine substituted renin inhibitors
DE3514695C2 (de) * 1985-04-24 1994-05-11 Merck Patent Gmbh Mittel und Verfahren zur Bestimmung von Calcium
EP0206807A3 (en) * 1985-06-28 1988-01-20 Kissei Pharmaceutical Co. Ltd. Novel amino acid derivatives
CA1290097C (en) * 1985-07-24 1991-10-01 Merck & Co., Inc. Peptide enzyme inhibitors
JPS6256458A (ja) * 1985-09-04 1987-03-12 Kissei Pharmaceut Co Ltd 新規なアミノ酸誘導体
US4853463A (en) * 1985-09-04 1989-08-01 Kissei Pharmaceutical Co., Ltd. Amino acid derivatives
DE3538749A1 (de) * 1985-10-31 1987-05-07 Merck Patent Gmbh Peptide
US4894437A (en) * 1985-11-15 1990-01-16 The Upjohn Company Novel renin inhibiting polypeptide analogs containing S-aryl-D- or L- or DL-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties
US4705846A (en) * 1986-03-27 1987-11-10 The Upjohn Company Novel renin inhibiting peptides having a gamma lactam pseudo dipeptide insert
JPS6322081A (ja) * 1986-07-11 1988-01-29 Kissei Pharmaceut Co Ltd 新規なアミノ酸誘導体
EP0321497A1 (en) * 1986-09-30 1989-06-28 The Upjohn Company Renin inhibitory peptides having novel c-terminal moieties
US4743585A (en) * 1986-11-21 1988-05-10 Warner-Lambert Company Renin inhibitors
US4804743A (en) * 1987-01-29 1989-02-14 Warner-Lambert Copmany Proline-containing renin inhibitors
DE59009945D1 (de) * 1989-02-10 1996-01-18 Wolfgang Prof Dr Schramm Mittel zur hemmung von hiv-proteasen.
CA2359030A1 (en) 1999-01-28 2000-08-03 Chugai Seiyaku Kabushiki Kaisha Substituted phenethylamine derivatives

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH14681A (en) * 1977-11-30 1981-11-10 Pfizer Phenylglycinamides useful in the treatment of ischaemic heart disease
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
CA1258748A (en) * 1981-10-08 1989-08-22 Daniel F. Veber Renin inhibitory peptides
US4478826A (en) * 1981-10-08 1984-10-23 Merck & Co., Inc. Renin inhibitory peptides
US4384994A (en) * 1981-10-08 1983-05-24 Merck & Co., Inc. Renin inhibitory peptides
US4470971A (en) * 1981-10-19 1984-09-11 Merck & Co., Inc. Renin inhibitory peptides having His13
CA1245217A (en) * 1981-12-10 1988-11-22 Joshua S. Boger Renin inhibitory peptides having phe su13 xx deletion
US4479941A (en) * 1981-12-10 1984-10-30 Merck & Co., Inc. Renin inhibitory peptides having PHE13 delection
FR2531951A1 (fr) * 1982-08-17 1984-02-24 Sanofi Sa Derives peptidiques inhibiteurs de proteases acides, procede pour leur preparation et medicaments qui en contiennent
EP0104041B1 (en) * 1982-09-15 1988-07-27 Aktiebolaget Hässle Enzyme inhibitors
US4485099A (en) * 1983-06-15 1984-11-27 Merck & Co., Inc. Renin inhibitors containing a C-terminal amide cycle

Also Published As

Publication number Publication date
FI834345L (fi) 1984-06-04
EP0111266A2 (de) 1984-06-20
GR79104B (es) 1984-10-02
DK555983A (da) 1984-06-04
FI834345A7 (fi) 1984-06-04
PT77761A (en) 1983-12-01
EP0111266A3 (de) 1987-05-27
ES8702437A1 (es) 1987-01-01
ES8606394A1 (es) 1986-04-01
PT77761B (en) 1986-05-30
DD217807A5 (de) 1985-01-23
DK555983D0 (da) 1983-12-02
ES543488A0 (es) 1987-01-01
NO834441L (no) 1984-06-04
FI834345A0 (fi) 1983-11-28
AU2193783A (en) 1984-06-07
IL70365A0 (en) 1984-03-30
US4595677A (en) 1986-06-17

Similar Documents

Publication Publication Date Title
ES543488A0 (es) Procedimiento para la obtencion de tetrapeptidos sustituidos
AR232000A1 (es) Procedimiento para la obtencion de pancreatina
ES524504A0 (es) Procedimiento para la obtencion de liposomas unilaminares
ES525803A0 (es) Procedimiento para la obtencion de derivados de feniletilamina
ES500791A0 (es) Procedimiento para la obtencion de polieterpolioles
ES553050A0 (es) Procedimiento para la obtencion de n-(piperidinil-alquil)-carboxamidas
ES533538A0 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
ES502573A0 (es) Procedimiento para la obtencion de imidazoazoalquenamidas
ES505910A0 (es) Procedimiento para la obtencion de metilformiato
MX7339E (es) Procedimiento mejorado para la obtencion de n- acrilamidas
ES525953A0 (es) Procedimiento para la obtencion de derivados piperazinicos
MX156530A (es) Procedimiento mejorado para la obtencion de carboximetilcelulosa
ES531103A0 (es) Procedimiento para la obtencion de benzofuranonas
ES526042A0 (es) Procedimiento para la obtencion de azolilbutanoles
ES526891A0 (es) Procedimiento para la obtencion de benzofuranonas
ES533988A0 (es) Procedimiento para la obtencion de mercaptocarboxilamidas
ES525257A0 (es) Procedimiento para la obtencion de poliamido-imidas
ES490475A0 (es) Procedimiento para la obtencion de metilolaminotriazinas eteradas
ES527054A0 (es) Procedimiento para la obtencion de derivados bis-quinazolinicos
ES535291A0 (es) Procedimiento para la obtencion de agentes termosensibilizadores
ES526672A0 (es) Procedimiento para la obtencion de latex cationicos
ES505406A0 (es) Procedimiento para la obtencion de n-(ciclohexiltio)-ftali- mida
ES537129A0 (es) Procedimiento para la obtencion de iodacetamidas
ES507522A0 (es) Procedimiento para la obtencion de 1-fenil-2-triazolil-1-penten-3--oles
ES527260A0 (es) Procedimiento para la obtencion de compuestos de 2-heterociclil-tio-alquilo inferior-penem